Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Latest On Transapical: Edwards Talks Up Sapien CAP Data

This article was originally published in The Gray Sheet

Executive Summary

The non-randomized continued access program, which enrolled 822 transapical patients beyond the original randomized enrollment of 104 transapical patients, tells an improving story for transapical delivery for Sapien.

Advertisement

Related Content

Edwards Reveals Sapien Launch Plans For Transapical Delivery Method
Market & Industry Briefs
Transcatheter Valve Coverage Proposal Reflects Stricter Medicare Environment
Reimbursement In Brief
Transcatheter Valves: Tough Love For Transapical Placement Method At TCT
CMS Jumps Out Ahead Of FDA With Transcatheter Valve Coverage Analysis
Getting Set For Sapien: With Data In, Discussion Moves To Adoption Dynamics

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT030950

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel